X0508 4 2026-02-10 0 0001224608 CNO Financial Group, Inc. CNO 0001438233 Zimpfer Matthew J. C/O CNO FINANCIAL GROUP, INC. 11299 ILLINOIS STREET, SUITE 200 CARMEL IN 46032 0 1 0 0 General Counsel 1 Common Stock 2026-02-10 4 A 0 25384 43.05 A 301300 D Common Stock 2026-02-10 4 F 0 7663 43.05 D 293637 D Restricted Stock Units 2026-02-10 4 A 0 14300 0 A 307937 D Common Stock 2026-02-12 4 M 0 30970 21.06 A 338907 D Common Stock 2026-02-12 4 S 0 30970 42.9313 D 307937 D Employee Stock Option (Right to Buy) 21.06 2026-02-12 4 M 0 30970 0 D 2027-02-23 Common Stock 30970 0 D Shares were acquired upon the vesting of performance share units for the 2023-2025 performance period, based on the issuer's (i) 2023 operating return on equity, (ii) 2023 operating earnings per share and (iii) three-year relative total shareholder return for 2023-2025. Shares were surrendered to the issuer to cover the required tax withholding on the vested performance share units. Restricted stock units convert into common stock on a one-for-one basis. The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.31 per share to $43.75 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. One-half of the stock options vested on February 23, 2019, and one-half vested on February 23, 2020. Heidi M. Krings, Attorney-in-Fact 2026-02-12